Aidian – Your aid in diagnostics
We are a leading Finnish-based in vitro diagnostics (IVD) company established in 1974. We develop, manufacture, and distribute reliable and fast CE marked diagnostic tests for point of care. Our aim is to aid global health by promoting efficient healthcare through accurate and fast diagnostics.Read more about us
Latest newsView all
Free access clinical webinars on iMg, estimated plasma volume, fetal lactate, and many other topics
26 June 2023 | News, Product news
QuikRead go® HbA1c is a reliable and effective test for the quantitative determination of HbA1c at the point of care
A new poster about QuikRead go® HbA1c is out now! A study conducted in the Netherlands shows that QuikRead go HbA1c is very well comparable to established IFCC and NGSP reference methods.
How CRP point of care testing aids primary care and guides sustainable use of antibiotics
Antimicrobial resistance (AMR) is a major global health threat. Aidian takes part in supporting antimicrobial stewardship and sustainable use of antibiotics in primary care. Watch our #TestBeforePrescribing animation series addressing AMR and how CRP point of care testing benefits primary care.
SIBA® licensing and partnering opportunities
SIBA® (Strand Invasion Based Amplification) is Aidian's proprietary isothermal nucleic acid amplification technology. The technology performs at a low and constant temperature avoiding the need of complex thermal cycling instrumentation. Well established SIBA answers to increasing demands on faster and more cost effective testing methods.